Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Follow-up systemic treatments
| N = 64 | |
|---|---|
| Number of treatments, n (%) | |
| Any subsequent treatment | 59 (92) |
| 1 subsequent treatment | 29 (45) |
| 2 subsequent treatments | 18 (28) |
| 3 subsequent treatments | 5 (8) |
| 4 subsequent treatments | 2 (3) |
| 5–10 subsequent treatments | 5 (8) |
| Type of medication†, n (%) | |
| Sorafenib | 29 (45) |
| Sunitinib | 26 (41) |
| Everolimus | 21 (33) |
| Axitinib | 10 (16) |
| Temsirolimus | 5 (8) |
| Interferon-α | 5 (8) |
Includes those administered to >5% of patients.
